Boston Scientific (BSX) Tops Q3 EPS by 4c; beats on guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.33 --0%
Revenue Growth %: +6.3%
Financial Fact:
Interest expense: -58M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +6.3%
Financial Fact:
Interest expense: -58M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.75, $0.04 better than the analyst estimate of $0.71. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $4.97 billion.
GUIDANCE:
Boston Scientific sees Q4 2025 EPS of $0.77-$0.79, versus the consensus of $0.76.
Boston Scientific sees FY2025 EPS of $3.02-$3.04, versus the consensus of $2.98.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
- Morgan Stanley Upgrades CDW Corporation (CDW) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
